Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia

NCT02787122 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2020-03-04

No results posted yet for this study

Summary

The present study is a pilot single-blind randomized controlled therapy study. Its aim is to assess the efficacy of an emotion-focussed form of Cognitive behavior Therapy that focusses on emotional processes that are involved in the formation and maintenance of delusions such as emotional stability, emotion regulation and self-esteem.

Conditions

  • Schizophrenia
  • Delusional Disorder
  • Schizoaffective Disorder
  • Brief Psychotic Disorder
  • Schizophreniform Disorder

Interventions

BEHAVIORAL

CBT-E

Patients receive 25 sessions of individual emotion-focused Cognitive Behavior Therapy based on a manual. Interventions aim on patients' mood by implementing positive activities in their daily routine. Further, patients train to reduce worrying behavior. Social contacts are fostered as well. Later, patients are informed on emotions and train emotion regulation strategies. Finally, the focus of CBT-E is on self-acceptance.Patients receive psychoeducation on self-acceptance and learn strategies in order to reduce negative self-schema and foster positive self-schema.

BEHAVIORAL

Treatment as Usual

Patients receive standardized treatment. After a waiting period of six month, patients receive CBT-E

Sponsors & Collaborators

  • University of Hamburg-Eppendorf

    collaborator OTHER
  • Philipps University Marburg

    lead OTHER

Principal Investigators

  • Stephanie Mehl, Ph. D. · Philipps University Marburg

  • Tania M. Lincoln · University of Hamburg-Eppendorf

  • Winfried Rief · Philipps University Marburg

  • Tilo Kircher · Philipps University Marburg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02787122 on ClinicalTrials.gov